Press "Enter" to skip to content

Posts tagged as “FDA”

Biden Administration Faces Legal Challenge to Restrict Access to Abortion Drug Mifepristone

The Biden administration is facing a legal challenge that could restrict access to the leading abortion drug in the U.S. A 19th century “anti-vice” law, the Comstock Act, has been revived by anti-abortion groups and conservative states in an effort to block the mailing of mifepristone. HHS Secretary Xavier Becerra has said that all options are on the table to ensure access to the drug, including Supreme Court intervention. Pro-choice advocates have criticized the ruling, arguing that it will have a negative impact on women’s health and rights.

Judge Appointed by Former President Trump Suspends FDA Approval of Abortion Pills, Sparking Outrage Among Congressional Democrats

A U.S. District Judge appointed by former President Donald Trump has suspended the FDA's approval of abortion pills, sparking outrage among Congressional Democrats. Chuck Schumer has urged Republicans to speak out against the ruling, while President Joe Biden has said his administration will file an appeal. Republicans in Congress have yet to respond to the ruling.

Federal Judge in Texas Issues Stay on FDA Approval of Mifepristone, Sparking Criticism from Abortion Rights Advocates and a Response from President Biden

A federal judge in Texas has issued a stay on the FDA's approval of mifepristone, a drug used for medication abortions, which has been met with criticism from abortion rights advocates. The U.S. Department of Justice and President Joe Biden have both released statements in response to the ruling, and the DOJ has filed an appeal and is seeking an immediate stay of the decision. The outcome of the DOJ's appeal could set a precedent for future cases and have a significant impact on access to abortion services in the United States.

Federal Judge Issues Injunction Suspending FDA Approval of Abortion Pill Mifepristone, Raising Questions Over Access to Abortion in the U.S.

A federal judge has issued an injunction suspending the Food and Drug Administration's (FDA) approval of the abortion pill mifepristone, potentially impacting access to medication abortions nationwide. U.S. District Judge Matthew Kacsmaryk ruled that the FDA's two-decade-old approval of the drug violated a federal rule and was unlawful. The government has a week to appeal the decision, which could have far-reaching implications for abortion access in the United States.

FDA Issues Class I Recall for Philips Respironics DreamStation1 CPAP Machines Due to Risk of Serious Injury or Death

This article discusses the FDA's Class I recall of certain Philips Respironics DreamStation1 CPAP machines due to incorrect or duplicate serial numbers during initial programming. Inhaling the foam from the recalled CPAP machines can cause serious injury or death, and Philips is offering a free replacement device to customers affected by the recall. The FDA is urging healthcare providers and patients to be aware of the recall and to report any adverse events or side effects related to the use of the recalled devices.

FDA Approves Over-the-Counter Naloxone Nasal Spray, Expected to Reduce Opioid Overdose Deaths Throughout the US

The US Food and Drug Administration (FDA) has approved an over-the-counter version of the opioid overdose reversal drug naloxone, increasing access to the lifesaving medication and providing an additional option for those who may not have access to a prescription or a pharmacy. This move is expected to reduce opioid overdose deaths throughout the country, and Dr. Scott Hadland, a pediatrician and an addiction specialist at MassGeneral Hospital for Children in Boston, believes it could save more lives. The FDA remains committed to addressing the evolving complexities of the overdose crisis.

GOOD Meat Receives FDA Approval for Lab-Grown Chicken, Bringing It One Step Closer to Grocery Store Shelves.

GOOD Meat has received a "no questions" letter from the FDA, indicating that the administration is satisfied that their lab-grown chicken product is safe to sell in the US. The company is now in talks with restaurants and food service companies about potential partnerships, and needs approval from the US Department of Agriculture in order to sell to consumers. If approved, GOOD Meat's lab-grown chicken would be the first of its kind to hit the market in the US, and is said to be more sustainable and healthier than traditional chicken.